In clinical trials, nivolumab (Opdivo) demonstrated a statistically significant improvement in recurrence-free survival compared to placebo in eligible patients with stages IIB, IIC, III, and stage IV completely resected melanoma.
My own experience has illustrated how embracing change can lead to growth.
AI systems can detect minute anomalies often missed by the human eye, reducing false negatives.
Margaret Ryman, BS, PharmD, BCPS, vice president of Health Systems at McKesson, discussed how she has seen the pharmacy field change and how she is celebrating this American Pharmacists Month.
Sindhuja Merugu, pharmacy technician at Health Mart Family Pharmacy discusses the role of the pharmacy technician, how the pharmacy technician profession has changed, and what is to come in the field.
Many patients would like more education about managing their asthma, which can help to reduce the overuse of short-acting beta-2 agonists.
The study results also indicate no significant difference of venous thromboembolism risk between individuals with immune-mediated inflammatory diseases and individuals without.
A study shows a significant increase in left ventricular ejection fraction when using pink noise stimulation with deep sleep.
Although increased knowledge and understanding could increase uptake and acceptability of pre-exposure prophylaxis for HIV, action is needed to remove barriers and improve accessibility.
Intranasal decongestants are preferred alternatives to oral phenylephrine for relief of nasal congestion.
Adolescents with mental health conditions must be monitored as they are at a higher demand for the need of mental health care.
As OTC hearing devices emerge and technologies advance, pharmacists can provide trustworthy recommendations and advice to patients
Trial data bolster the role of nivolumab and nivolumab-based combinations in both early and metastatic stages of multiple cancer types, especially in patient groups with high unmet needs.
TRPV1 inhibition overcomes cisplatin resistance by blocking autophagy-mediated hyperactivation of the EGFR signaling pathway.
Karline Peal, MBA of Vanderbilt Ingram Cancer Center discusses the positive impact technology has had in health care and how it can be implemented in the future.
Larger institutions have continued to treat patients who needed carboplatin or cisplatin; however, the survey results don’t include smaller cancer centers that may face access challenges.
Jacinda Abdul-Mutakabbir, PharmD, MPH, AAHIVP, discusses being the second pharmacist in IDSA history to receive a society award and what this means not only for her, but for the field.
SYNCHRONIZE-1, SYCHRONIZE-2, SYNCHRONIZE-CVOT will evaluate survodutide for overweight and obesity.
Investigators suggest that the Bacille Calmette–Guérin vaccine, which prevented tuberculosis in nonhuman primates infected with SIV, can also protect against HIV.
Contrary to earlier advice, new research suggests introducing infants to potential allergens early may reduce risk of developing allergies to those foods
The president of HOPA discusses the importance of mentorship in oncology pharmacy as well as the value of HOPA’s mentorship initiatives.
Although education and training have historically been considered the primary factors influencing pay, the survey results challenge this notion.
Pharmacists should educate patients on proper application of OTC hair loss products and help identify any medications that may be contributing.
Although the brand name manufacturer updated the label after the FDA’s request, generic manufacturers have not all followed suit.
Encorafenib (Braftovi; Pfizer Inc) and binimetinib (Mektovi; Pfizer Inc) approved for the treatment of patients with metastatic non-small cell lung cancer who harbor a BRAF V600E mutation.
Collaboration between AI-based platforms and health care organizations offers promising results.
New products and medications can be used as single agents or in combination with other agents for optimal treatment outcomes.
Jennifer Mathieu, MA from the Academy of Managed Care Pharmacy (AMCP) discusses what to expect from AMCP Nexus 2023 and some of the sessions she is looking forward to.
Aducanumab, lecanemab, and donanemab are novel monoclonal antibodies designed to slow disease progression and hopefully have a positive impact in the field of Alzheimer disease management.
